Related references
Note: Only part of the references are listed.Comparison of Local Control of Brain Metastases With Stereotactic Radiosurgery vs Surgical Resection A Secondary Analysis of a Randomized Clinical Trial
Thomas M. Churilla et al.
JAMA ONCOLOGY (2019)
A randomized phase II trial of trastuzumab plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and taxanes: WJOG6110B/ELTOP
Toshimi Takano et al.
BREAST (2018)
Medical management of brain metastases and leptomeningeal disease in patients with breast carcinoma
Kelsey M. Bowman et al.
FUTURE ONCOLOGY (2018)
Neuro-oncology perspective of treatment options in metastatic breast cancer
Riccardo Soffietti et al.
FUTURE ONCOLOGY (2018)
Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study
Rashmi Murthy et al.
LANCET ONCOLOGY (2018)
Surgical resection and postoperative radiosurgery versus staged radiosurgery for large brain metastases
Ammoren E. Dohm et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
The Multifarious Role of Microglia in Brain Metastasis
Manuel Sarmiento Soto et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
A matched-pair analysis comparing whole-brain radiotherapy with and without a stereotactic boost for intracerebral control and overall survival in patients with one to three cerebral metastases
Dirk Rades et al.
RADIATION ONCOLOGY (2017)
Current challenges in the management of breast cancer brain metastases
Ciara C. O'Sullivan et al.
SEMINARS IN ONCOLOGY (2017)
Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis
Gail D. Lewis Phillips et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases A Randomized Clinical Trial
Paul D. Brown et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Breast cancer brain metastases - A 12 year review of treatment outcomes
P. B. De Ieso et al.
BREAST (2015)
Phase 3 Trials of Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for 1 to 4 Brain Metastases: Individual Patient Data Meta-Analysis
Arjun Sahgal et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study
Masaaki Yamamoto et al.
LANCET ONCOLOGY (2014)
Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology
Muhammet Ali Kaplan et al.
BREAST CANCER (2014)
Systemic treatment after whole-brain radiotherapy may improve survival in RPA class II/III breast cancer patients with brain metastasis
Qian Zhang et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Selective Permeabilization of the BloodBrain Barrier at Sites of Metastasis
John J. Connell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01)
Bernhard C. Pestalozzi et al.
LANCET ONCOLOGY (2013)
Clinical implication of Time To Brain Metastasis (TTBM) according to breast cancer subtypes
Hee Kyung Ahn et al.
SPRINGERPLUS (2013)
Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model
Eun-Joo Park et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine
G. Metro et al.
ANNALS OF ONCOLOGY (2011)
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
Martin Kocher et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases - the UK experience
S. Sutherland et al.
BRITISH JOURNAL OF CANCER (2010)
DIAGNOSIS-SPECIFIC PROGNOSTIC FACTORS, INDEXES, AND TREATMENT OUTCOMES FOR PATIENTS WITH NEWLY DIAGNOSED BRAIN METASTASES: A MULTI-INSTITUTIONAL ANALYSIS OF 4,259 PATIENTS
Paul W. Sperduto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
DEGRO Practical Guidelines for Palliative Radiotherapy of Breast Cancer Patients: Brain Metastases and Leptomeningeal Carcinomatosis
Petra Feyer et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2010)
Trastuzumab treatment beyond brain progression in HER2-positive metastatic breast cancer
I. H. Park et al.
ANNALS OF ONCOLOGY (2009)
Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients
Cyrus Chargari et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
Eric L. Chang et al.
LANCET ONCOLOGY (2009)
Chemotherapy in breast cancer patients with brain metastases: Have new chemotherapic agents changed the clinical outcome?
Alicia Tosoni et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial
Alexander Muacevic et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
The role of efflux and uptake transporters in N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, Lapatinib) disposition and drug interactions
Joseph W. Polli et al.
DRUG METABOLISM AND DISPOSITION (2008)
Brain metastases in breast cancer: prognostic factors and management
Sung Sook Lee et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer
Rupert Bartsch et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Capecitabine therapy of central nervous system metastases from breast cancer
Meltem Ekenel et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Multidisciplinary management of brain Metastases
April F. Eichler et al.
ONCOLOGIST (2007)
Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier
Hans-Joachim Stemmler et al.
ANTI-CANCER DRUGS (2007)
Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab
T Yau et al.
ACTA ONCOLOGICA (2006)
Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer
MD Pegram et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer
MLH Wang et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2001)
Share Paper
